Preclinical Insights Into Intravitreal Gene Therapy for Rare Retinal Diseases
Time: 1:30 pm
day: Day Two 12th
Details:
- Explore the pioneering use of AAV based intravitreal gene therapies for treating Blue Cone Monochromacy and Achromatopsia
- Examine preclinical data and draw insights from preclinical models to assess the efficacy and safety profiles of intravitreal gene therapy for rare inherited retinal diseases
- Explore strategies for optimizing the delivery of gene therapies via intravitreal administration such as dosage and administration techniques that influence the therapeutic outcome and durability of treatment effects